Answers are grounded in this paper and cite their sources.
This study aimed to evaluate the correlation between atherogenic index of plasma (AIP) and prevalence of reduced estimated glomerular filtration rate (eGFR). This cross-sectional study included 4885 participants aged ≥60 from southeast China from 13 September 2023 to 30 November 2023. AIP was calculated as the logarithmic ratio (base 10) of triglycerides to high-density lipoprotein cholesterol. This study used categorical age-adapted eGFR thresholds in two age groups to analyze: <60 mL/min/1.73 m2 for those aged 60–65 years old and <45 mL/min/1.73 m2 for those over 65 years old. The category-free analysis was performed to corroborate whether AIP enhanced the ability to estimate reduced eGFR. The prevalence of reduced eGFR in the general population aged ≥60 was 2.7%. After adjustment, each SD increase in AIP was associated with a 52% additional risk for reduced eGFR. When dividing AIP into quartiles, the top quartile had a 2.95 times higher risk than the bottom quartile. Subgroup analysis revealed that the association remained robust against several risk factors for renal damage. This study reveals an association between AIP and reduced eGFR with age-adapted eGFR thresholds, independent of conventional risk factors.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: